Updated:
Taiho Ventures
Taiho Ventures, LLC is the corporate venture arm of Taiho Pharmaceutical Co., Ltd., a Japanese specialty pharmaceutical company focusing on oncology, allergy...
Taiho Ventures
Taiho Ventures, LLC is the corporate venture arm of Taiho Pharmaceutical Co., Ltd., a Japanese specialty pharmaceutical company focusing on oncology, allergy and immunology, and urology. With $400M under management, it actively invests in early stage private companies strategically relevant to Taiho Pharmaceutical. It considers company creation, spinouts and the option-type of investments as well as pure equity investments. Its mission is to create significant values from investing in the global biotech venture community and provide innovative science for Taiho Pharmaceutical Co., Ltd.
General information
Firm type
Venture Capital
Year founded
2017
Location
Region
Middle East
Country
United States
City
Menlo Park
Corporate office
Menlo Park, CA, United States
Additional offices
Abu Dhabi, United Arab Emirates · Princeton, NJ, United States · Chicago, IL, United States
Principals
Sakae Asanuma
Founder & Managing Partner
Sector focus
Frequently asked questions
Who leads investment decisions at Taiho Ventures?
Founder and Managing Partner Sakae Asanuma chairs the investment committee, drawing on his tenure as President of Astellas Pharma US. Day-to-day deal sourcing and diligence is conducted by a core team spread across the Menlo Park, Princeton, and Abu Dhabi offices, blending pharmaceutical operational experience with institutional venture backgrounds.
How is Taiho Ventures related to Taiho Pharmaceutical?
The firm operates independently but maintains a strategic relationship with Taiho Pharmaceutical, a Japanese oncology-focused pharma company that is one of its capital partners. Taiho Ventures is not a captive corporate venture arm; it manages capital from multiple sources, including family offices and sovereign-linked entities, allowing it to pursue investments beyond the parent pharma's immediate pipeline priorities.
Does Taiho participate in fund commitments or only direct deals?
Taiho Ventures is structured for direct early-stage equity investments and spin-off financings. There is no public record of the firm allocating to third-party venture funds as a limited partner, reinforcing its posture as a direct, thesis-driven investor rather than a fund-of-funds allocator.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: